• DCE-MRI Quantitative Technique Subject •
Dynamic contrast-enhanced MRI in the differential diagnosis of high grade glioma, low grade glioma and meningioma
DOI:10.3969/j.issn.1674-8034.2015.08.002.
| [Abstract] Objective: Through undergoing dynamic contrast-enhanced MRI (dynamic contrast-enhanced MRI, DCE-MRI) before operation to provide quantitative basis for the differential diagnosis of the three kinds of tumors.Materials and Methods: Nineteen cases of gliomas (7 with low grade, 12 with high grade) and 19 cases of meningiomas (13 with benign, 6 with malignant or anaplastic) were enrolled. The pharmacokinetic model of Extended Tofts Linear was used to calculate the datas, the tissue enhancement-time curve and pharmacokinetic parameters (volume transfer constant, Ktrans, extracellular extravascular volume fraction, Ve; and blood plasma fraction, Vp) of the lesion, solid components were obtained. Ktrans value, Ve value and Vp value were compared to judge whether there were significant differences between the three kinds of tumors.Results: The values of Ktrans and Ve in high grade glioma (HGG) were significantly higher than the low grade glioma(LGG) (P<0.05); Vp values of high grade glioma were slightly higher than the low grade glioma, but the difference was not statistically significant; The values of Ktrans and Ve in meningiomas were significantly higher than the low grade gliomas (P<0.05), but the difference of Vp values were not statistically significant; the differences of Ktrans, Ve, Vp of gliomas and meningiomas were not statistically significant (P>0.05).Conclusion: DCE-MRI can effectively distinguish low grade glioma from high grade glioma and low grade glioma from meningioma, At the same time, DCE-MRI improves the diagnosis accuracy of glioma and invasive meningioma through the quantitative analysis . |
| [Keywords] Magnetic resonance imaging；Dynamic contrast-enhancement；Glioma；Meningioma；Pharmacokinetic parameters |
ZHANG Wei Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
NIU Lei Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
MA Min-ge Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
ZHOU Hao Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
LIU Xue-jun Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
FENG Wei-hua Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
SUI Qing-lan* Department of Radiology, The Afflilated Hospital of Qingdao University, Qingdao 266000, China
*Correspondence to: Sui QL, E-mail: suiql@163.com
Conflicts of interest None.
| Received 2015-05-31 |
| Accepted 2015-06-12 |
| DOI: 10.3969/j.issn.1674-8034.2015.08.002 |
| DOI:10.3969/j.issn.1674-8034.2015.08.002. |
[1]
李晓光，康厚艺，程海云，等. T1加权像动态对比增强MRI在评价脑胶质瘤微血管通透性及病理分级中的应用价值．蚌埠医学院学报, 2015, 40(2): 230-233.
[2]
季学满，武洪林，卢光明．动态对比增强灌注磁共振成像在颅脑肿瘤的应用．医学研究所学报, 2004, 17(1): 87-89.
[3]
杜学松，刘恒，陈晓．动态对比增强MRI评价大鼠C6胶质瘤肿瘤边缘新生血管的实验研究．中国医学影像学杂志, 2015, 23(2): 81-86.
[4]
林蒙，罗德红．动态增强MRI在颅底及颈部肿瘤中的应用价值．中国肿瘤影像学, 2009, 2(4): 150-153.
[5]
白雪冬，孙夕林，王丹．动态对比增强MRI在鉴别胶质瘤复发及放射性脑损伤中的应用．磁共振成像, 2014, 5(1): 1-6.
[6]
Turkbey B, Thomasson D, Pang Y, et al. The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiology, 2010, 16(3): 186-192.
[7]
Zaharchuk G. Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol, 2007, 28(10): 1850-1858.
[8]
Provenzale JM, Mukundan S, Dewhirst M. The role of bloodbrain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol, 2005, 185(3): 763-767.
[9]
Kassner A. Thornhill R Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging. Methods Mol Biol, 2011, 686: 229-245.
[10]
Zhang N, Zhang L, Qiu B, et al. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging, 2012, 36(2): 355-363.
[11]
Almeida-Freitas DB, Pinho MC, Otaduy MC, et al. Assessment of irradiated brain metastases using dynamic contrast-enhanced magnetic resonance imaging. Neuroradiology, 2014, 56(6): 437-443.
[12]
张宁男楠，张云亭，张敬，等．幕上毛细胞型星形细胞瘤影像学表现．天津医科大学学报, 2010, 16(4): 638-641.
[13]
黄杰，李晓光，康厚艺，等. DSC-MRI和DCE-MRI定量分析在脑胶质瘤分级诊断中的应用．第三军医大学学报, 2015, 37(7): 672-677.
[14]
Bergamino M, Bonzano L, Levrero F, et al. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)in human brain tumors. Phys Med, 2014, 30(6): 635-643.
[15]
Alcaide-Leon P, Rovira A. Dynamic contrast-enhanced MR: importance of reaching the washout phase. AJNR Am J Neuroradiol, 2013, 34(5): E60.
[16]
Larsson C, Kleppestø M, Rasmussen I Jr, et al. Sampling requirements in DCE-MRI based analysis of high grade gliomas:simulations and clinical results. J Magn Reson Imaging, 2013, 37(4): 818-829.
[17]
贾中正，张军，汤伟军. DCE-MRI评估脑胶质瘤微血管通透性．中国医学计算机成像杂志, 2013, 19(4): 293-297.
[18]
邓振生，张娜，孟莉．利用T1加权DCE-MRI技术对脑胶质瘤分级.中国生物医学工程学报, 2010, 29(1): 16-21.
[19]
赵斌．磁共振灌注成像临床应用及进展．磁共振成像, 2014, 5(S1): 46-50.
[20]
Bergamino M, Barletta L, Castellan L, et al. Evaluation of IAUGC indices and two DCE-MRI pharmacokinetic parameters assessed by two different theoretical algorithms in patients with brain tumors. Clin Imaging, 2014, 38(6): 808-814.
